Search details
1.
Cost-effectiveness of ivosidenib versus chemotherapy for previously treated IDH1-mutant advanced intrahepatic cholangiocarcinoma in Taiwan.
BMC Cancer
; 24(1): 622, 2024 May 22.
Article
in English
| MEDLINE | ID: mdl-38778261
2.
Germline mutations of homologous recombination genes and clinical outcomes in pancreatic cancer: a multicenter study in Taiwan.
J Biomed Sci
; 31(1): 21, 2024 Feb 13.
Article
in English
| MEDLINE | ID: mdl-38350919
3.
Impact of previous S-1 treatment on efficacy of liposomal irinotecan plus 5-fluorouracil and leucovorin in patients with metastatic pancreatic cancer.
Pancreatology
; 2024 Mar 25.
Article
in English
| MEDLINE | ID: mdl-38565467
4.
Cost-effectiveness of pemigatinib as a second-line treatment for advanced intrahepatic cholangiocarcinoma with fibroblast growth factor receptor 2 fusions in Taiwan: from the evidence of the phase II trial and the perspective of Taiwan's National Health Insurance Administration.
Cost Eff Resour Alloc
; 21(1): 61, 2023 Sep 11.
Article
in English
| MEDLINE | ID: mdl-37697368
5.
A phase II randomised trial of induction chemotherapy followed by concurrent chemoradiotherapy in locally advanced pancreatic cancer: the Taiwan Cooperative Oncology Group T2212 study.
Br J Cancer
; 126(7): 1018-1026, 2022 04.
Article
in English
| MEDLINE | ID: mdl-34921230
6.
CHK2 activation contributes to the development of oxaliplatin resistance in colorectal cancer.
Br J Cancer
; 127(9): 1615-1628, 2022 11.
Article
in English
| MEDLINE | ID: mdl-35999268
7.
Transferrin and Prealbumin Identify Esophageal Cancer Patients with Malnutrition and Poor Prognosis in Patients with Normal Albuminemia: A Cohort Study.
Nutr Cancer
; 74(10): 3546-3555, 2022.
Article
in English
| MEDLINE | ID: mdl-35652575
8.
Phase I Dose-Escalation Study of SCB01A, a Microtubule Inhibitor with Vascular Disrupting Activity, in Patients with Advanced Solid Tumors.
Oncologist
; 26(4): e567-e579, 2021 04.
Article
in English
| MEDLINE | ID: mdl-33245172
9.
AUY922 induces retinal toxicity through attenuating TRPM1.
J Biomed Sci
; 28(1): 55, 2021 Jul 23.
Article
in English
| MEDLINE | ID: mdl-34301262
10.
Validation of genome-wide association study-identified single nucleotide polymorphisms in a case-control study of pancreatic cancer from Taiwan.
J Biomed Sci
; 27(1): 69, 2020 May 26.
Article
in English
| MEDLINE | ID: mdl-32456644
11.
Multicentre, phase II study of gemcitabine and S-1 in patients with advanced biliary tract cancer: TG1308 study.
Liver Int
; 40(10): 2535-2543, 2020 10.
Article
in English
| MEDLINE | ID: mdl-32463975
12.
Review of preclinical and clinical studies of using cell-based therapy for secondary lymphedema.
J Surg Oncol
; 121(1): 109-120, 2020 Jan.
Article
in English
| MEDLINE | ID: mdl-31385308
13.
Adjuvant therapy in biliary tract cancers: oral fluoropyrimidine as a beginning.
Lancet
; 401(10372): 170-171, 2023 01 21.
Article
in English
| MEDLINE | ID: mdl-36681404
14.
Radiotherapy for inferior vena cava tumor thrombus in patients with hepatocellular carcinoma.
BMC Cancer
; 19(1): 560, 2019 Jun 10.
Article
in English
| MEDLINE | ID: mdl-31182065
15.
A phase I dose-escalation study of PEP02 (irinotecan liposome injection) in combination with 5-fluorouracil and leucovorin in advanced solid tumors.
BMC Cancer
; 16(1): 907, 2016 11 21.
Article
in English
| MEDLINE | ID: mdl-27871319
16.
The potent activation of Ca(2+)-activated K(+) current by NVP-AUY922 in the human pancreatic duct cell line (PANC-1) possibly independent of heat shock protein 90 inhibition.
J Pharmacol Sci
; 127(4): 404-13, 2015 Apr.
Article
in English
| MEDLINE | ID: mdl-25953267
17.
The epidemiology of gastrointestinal stromal tumors in Taiwan, 1998-2008: a nation-wide cancer registry-based study.
BMC Cancer
; 14: 102, 2014 Feb 18.
Article
in English
| MEDLINE | ID: mdl-24548660
18.
Stimulation of electroporation-induced inward currents in glioblastoma cell lines by the heat shock protein inhibitor AUY922.
Clin Exp Pharmacol Physiol
; 41(10): 830-7, 2014 Oct.
Article
in English
| MEDLINE | ID: mdl-24909268
19.
An integrated microfluidic system for automatic detection of cholangiocarcinoma cells from bile.
Lab Chip
; 24(2): 375-382, 2024 01 17.
Article
in English
| MEDLINE | ID: mdl-38126571
20.
Cost-Effectiveness Analysis of a New Second-Line Treatment Regimen for Advanced Intrahepatic Cholangiocarcinoma: Biomarker-Driven Targeted Therapy of Pemigatinib Versus 5-FU Chemotherapy.
Pharmacoeconomics
; 41(3): 307-319, 2023 03.
Article
in English
| MEDLINE | ID: mdl-36575331